Jae J. Kim

Jae J. Kim


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2010 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
Hyuk LeeHyuk Lee
Hyuk Lee
WYWon Kyoung Yun
Won Kyoung Yun
BMByung-Hoon Min
Byung-Hoon Min
JLJun Haeng Lee
Jun Haeng Lee
PRPoong-Lyul Rhee
Poong-Lyul Rhee
JKJae J. Kim
Jae J. Kim

25 June 2015 in Endoscopy
Verified
Journal Article
Closed access
PDF file
BMByung-Hoon Min
Byung-Hoon Min
EKEun Ran Kim
Eun Ran Kim
KKKyoung-Mee Kim
Kyoung-Mee Kim
CPCheol Keun Park
Cheol Keun Park
JLJun Haeng Lee
Jun Haeng Lee
JKJae J. Kim
Jae J. Kim
Background and study aims: To suggest an appropriate surveillance strategy after curative endoscopic submucosal dissection (ESD) for early gastric cancers, based on incidence and patterns of local, metachronous, and extragastric recurrence. Patients and methods: Between 2003 and 2011, 1497 consecutive patients with 1539 differentiated-type early gastric cancers meeting absolute or expanded indication criteria underwent curative ESD. They were followed up with esophagogastroduodenoscopy (EGD) and abdominal computed tomography (CT) under a standardized surveillance protocol. Long-term outcomes were analyzed for 1306 patients with at least 1 year’s follow-up. Results: Incidences of residual and synchronous lesions detected within 1 year were 0.13 % and 0.87 %, respectively. During median 47 months of follow-up, there was 1 local recurrence (0.08 %; early gastric cancer) and 47 cases of metachronous recurrence (3.6 %; 44 early gastric cancers, 3 pT2 advanced gastric cancers); all were curatively treated. During a 5-year surveillance, the cumulative incidence curve of metachronous recurrence increased linearly. Median time from ESD to metachronous recurrence was 30 months. There were 2 extragastric recurrences (0.15 %) in lymph nodes, at 5 and 4 years, respectively, after curative ESD for absolute and expanded indications. The patient with the expanded indications underwent a palliative operation and died of gastric cancer progression. Conclusions: There was a constant incidence rate of metachronous recurrence during a 5-year surveillance period and there was extragastric recurrence at least 4 years after ESD of early gastric cancer even for absolute indications. Therefore, annual or biannual surveillance EGD and abdominal CT might be necessary for at least 5 years after curative ESD for early gastric cancers, with absolute as well as expanded indications. * Byung-Hoon Min and Eun Ran Kim contributed equally to this work.

16 October 2015 in Helicobacter
Verified
Journal Article
Closed access
PDF file
WSWoon Geon Shin
Woon Geon Shin
SLSang Woo Lee
Sang Woo Lee
GBGwang Ho Baik
Gwang Ho Baik
KHKyu Chan Huh
Kyu Chan Huh
SLSang In Lee
Sang In Lee
JKJae J. Kim
Jae J. Kim

30 December 2009 in Gut and Liver
Verified
Journal Article
Open access
PDF file
AHA-Reum Han
A-Reum Han
CSChang Ohk Sung
Chang Ohk Sung
KKKyoung Mee Kim
Kyoung Mee Kim
CPCheol-Keun Park
Cheol-Keun Park
BMByung-Hoon Min
Byung-Hoon Min
JKJae J. Kim
Jae J. Kim
Han AR, et al. Gut Liver. 2009 Dec;3(4):271-275. http://dx.doi.org/10.5009/gnl.2009.3.4.271

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
YMYang Won Min
Yang Won Min
BMByung-Hoon Min
Byung-Hoon Min
JLJun Haeng Lee
Jun Haeng Lee
JKJae J. Kim
Jae J. Kim
Gastric cancer remains one of the most common causes of cancer death. However the proportion of early gastric cancer (EGC) at diagnosis is increasing. Endoscopic treatment for EGC is actively performed worldwide in cases meeting specific criteria. Endoscopic mucosal resection can treat EGC with comparable results to surgery for selected cases. Endoscopic submucosal dissection (ESD) increases the en bloc and complete resection rates and reduces the local recurrence rate. ESD has been performed with expanded indication and is expected to be more widely used in the treatment of EGC through the technological advances in the near future. This review will describe the techniques, indications and outcomes of endoscopic treatment for EGC.

30 December 2011 in Gut and Liver
Verified
Journal Article
Open access
PDF file
KKKi Joo Kang
Ki Joo Kang
KKKyoung-Mee Kim
Kyoung-Mee Kim
BMByung-Hoon Min
Byung-Hoon Min
JLJun Haeng Lee
Jun Haeng Lee
JKJae J. Kim
Jae J. Kim
Kang KJ, et al. Gut Liver. 2011 Dec;5(4):418-426. http://dx.doi.org/10.5009/gnl.2011.5.4.418